左心室辅助装置 (LVAD) 的全球市场

到 2030 年，全球左心室辅助装置 (LVAD) 市场将达到 26 亿美元

左心室辅助装置 (LVAD) 的全球市场预计到 2023 年将达到 15 亿美元，预计在 2023 年至 2030 年分析期间将以 7.6% 的复合年增长率增长，并在 2030 年达到 26 亿美元。医院最终用途是本报告分析的细分市场之一，预计复合年增长率为 6.1%，到分析期结束时将达到 13 亿美元。分析期间，临床最终用途细分市场的复合年增长率预计为 9.9%。

美国市场预估为4.234亿美元，中国预期复合年增长率为7.2%

预计 2023 年美国左心室辅助装置 (LVAD) 市场规模将达到 4.234 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 4.027 亿美元，2023-2030 年分析期间复合年增长率为 7.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.8% 和 6.4%。在欧洲，德国的复合年增长率预计约为 6.2%。

全球左心室辅助装置 (LVAD) 市场 - 主要趋势和驱动因素总结

什么是左心室辅助循环装置（LVAD）？

左心室辅助装置 (LVAD) 是一种机械泵，用于支持心臟虚弱或严重心臟衰竭患者的心臟功能和血流。 LVAD 通常在治疗不再有效时使用，并在患者等待捐赠心臟时提供关键支持，作为心臟移植的桥樑。另外，对于不适合移植的患者，LVAD 可以作为目标治疗，并提供长期支持作为护理标准。这些装置透过手术植入，透过从左心室抽取血液并将其输送到主动脉来工作，有效地补充或取代心臟主室的泵血功能。 LVAD 技术的进步显着提高了患者的生活品质和存活率，使该设备成为治疗晚期心臟衰竭的重要选择。

技术创新如何形塑 LVAD 市场？

LVAD 设计和功能的技术进步极大地提高了其有效性和患者适用性。现代 LVAD 更加紧凑、侵入性更小，并采用连续流动技术，可降低血栓和感染疾病等设备相关併发症的风险。磁力轴承和动态轴承等创新技术可最大限度地减少设备的物理磨损，延长其使用寿命和可靠性。此外，与以前的限制性更强的型号相比，电池寿命和便携性的提高使患者拥有更多的自由度和移动性。这些技术进步不仅增加了 LVAD 的盛行率，而且扩大了 LVAD 植入的潜在候选人群，包括老年患者和健康状况复杂的患者。

LVAD市场存在哪些挑战与机会？

儘管取得了重大进展，LVAD 市场仍面临影响患者治疗结果和广泛采用的挑战。移植手术的侵入性以及出血、中风和感染等严重併发症的风险是阻碍潜在候选人的重要担忧。此外，新兴国家的 LVAD 成本（包括设备本身、手术和术后护理）仍然让许多患者和医疗保健系统望而却步，尤其是在低度开发国家。然而，这些挑战也为市场创新和成长提供了机会。不断需要研究和开发来创造能够解决这些问题的侵入性较小、可靠且具有成本效益的设备。显着改善患者治疗效果的潜力继续推动人们对开发能够克服当前局限性的下一代 LVAD 的投资和兴趣。

LVAD 市场成长由多种因素推动

LVAD 市场的成长是由反映人口趋势、技术进步和医疗保健发展的多种因素所推动的。全球心臟衰竭盛行率不断上升，加上世界人口老化，导致对 LVAD 等先进治疗方案的需求增加。提高使用这些设备的患者的安全性和生活品质的技术创新是使其对患者和临床医生更具吸引力的关键驱动因素。此外，患者选择和术前护理的改进正在优化 LVAD 患者的治疗效果，并提高该治疗方法的成功率和可靠性。最后，一些国家医疗保健支出的增加和先进医疗保险覆盖范围的扩大，使得 LVAD 可供更广泛的患者使用，进一步刺激了市场成长。这些因素共同促进了 LVAD 市场的动态扩张，使 LVAD 成为现代心臟治疗的重要组成部分。

调查企业举例（共13家）

• Evaheart, Inc.
• Peripal AG

目录

第一章调查方法

第 2 章执行摘要

• 市场概况
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 其他欧洲国家
• 亚太地区
• 其他领域

第四章 比赛

Global Left Ventricular Assist Device (LVAD) Market to Reach US$2.6 Billion by 2030

The global market for Left Ventricular Assist Device (LVAD) estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Clinics End-Use segment is estimated at 9.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$423.4 Million While China is Forecast to Grow at 7.2% CAGR

The Left Ventricular Assist Device (LVAD) market in the U.S. is estimated at US$423.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$402.7 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Left Ventricular Assist Device (LVAD) Market - Key Trends & Drivers Summarized

What Are Left Ventricular Assist Devices (LVADs) and How Do They Support Heart Health?

Left Ventricular Assist Devices (LVADs) are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts or severe heart failure. Typically employed when medical treatments are no longer effective, LVADs can be used as a bridge to heart transplantation, providing vital support while a patient awaits a donor heart. Alternatively, for patients who are not candidates for transplantation, LVADs can be used as a destination therapy, offering long-term support as a standard of care. These devices are surgically implanted and work by taking blood from the left ventricle and pumping it to the aorta, effectively aiding or taking over the pumping function of the heart's main chamber. Advances in LVAD technology have significantly improved the quality of life and survival rates for patients, making these devices a crucial option in managing advanced heart failure.

How Is Technological Innovation Shaping the LVAD Market?

Technological advancements in the design and functionality of LVADs have dramatically enhanced their effectiveness and patient compatibility. Modern LVADs are more compact, less invasive, and equipped with continuous flow technology that reduces the risk of device-related complications, such as blood clots and infections. Innovations such as magnetic and hydrodynamic bearings have minimized the physical wear on the device, extending their usable life and reliability. Additionally, improvements in battery life and portability allow patients more freedom and mobility than earlier models, which were more restrictive. These technological improvements have not only increased the adoption rates of LVADs but have also broadened the potential candidate pool for LVAD implantation, including older patients and those with complex health profiles.

What Challenges and Opportunities Exist Within the LVAD Market?

Despite significant advancements, the LVAD market faces challenges that affect both patient outcomes and broader adoption. The invasive nature of the implantation procedure and the risk of serious complications such as bleeding, stroke, and infection are considerable concerns that can deter potential candidates. Moreover, the cost of LVADs, including the device itself, surgery, and post-operative care, remains prohibitively high for many patients and healthcare systems, particularly in less developed countries. However, these challenges also present opportunities for innovation and growth within the market. There is a constant demand for research and development to produce less invasive, more reliable, and cost-effective devices that could address these issues. The potential for significant improvements in patient outcomes continues to drive investment and interest in developing next-generation LVADs that could overcome current limitations.

Growth in the LVAD Market Is Driven by Several Factors

The growth in the LVAD market is driven by several factors, reflecting a combination of demographic trends, technological advancements, and evolving healthcare practices. Increasing prevalence of heart failure worldwide, coupled with an aging global population, has resulted in a higher demand for advanced treatment options like LVADs. Technological innovations that enhance the safety and quality of life for patients using these devices are key growth drivers, making the devices more appealing to both patients and clinicians. Additionally, improvements in patient selection and pre-operative care have optimized outcomes for LVAD recipients, increasing the success rates and confidence in this treatment approach. Finally, growing healthcare expenditures and expanding insurance coverage for advanced medical treatments in several countries are making LVADs accessible to a broader range of patients, further stimulating market growth. These factors collectively contribute to the dynamic expansion of the LVAD market, making it a vital component of modern cardiac care.

Select Competitors (Total 13 Featured) -

• Evaheart, Inc.
• Peripal AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Left Ventricular Assist Device (LVAD) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Left Ventricular Assist Device (LVAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: USA 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: Canada 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• JAPAN
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: Japan 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• CHINA
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: China 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• EUROPE
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• FRANCE
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: France 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• GERMANY
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Germany 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Italy 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: UK 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Rest of Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Rest of Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Asia-Pacific Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Asia-Pacific 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of World Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION